✦ LIBER ✦

Cost-effectiveness of homologous recombination defect testing to target PARP inhibitor use in platinum-sensitive recurrent ovarian cancer

✍ Scribed by A. Alvarez-Secord; J. Barnett; J. Ledermann; B. Peterson; E. Myers; L. Havrilesky

Book ID: 113963778
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 141 KB
Volume: 125
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2011.12.223

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinicopathological Features of Homologo

Clinicopathological Features of Homologous Recombination-Deficient Epithelial Ovarian Cancers: Sensitivity to PARP Inhibitors, Platinum, and Survival

✍ Mukhopadhyay, A.; Plummer, E. R.; Elattar, A.; Soohoo, S.; Uzir, B.; Quinn, J. E 📂 Article 📅 2012 🏛 American Association for Cancer Research 🌐 English ⚖ 388 KB